Privi Speciality Chemicals has announced that its Board of Directors will convene on May 11, 2026. The primary agenda includes the consideration and approval of the company’s audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Additionally, the Board will discuss the declaration of a final dividend for equity shareholders, marking a significant event in the company’s annual financial calendar.
Upcoming Board Meeting Details
The company has scheduled a formal meeting of its Board of Directors for Monday, May 11, 2026. The meeting will take place at the corporate office in Navi Mumbai, with provisions made for directors to join via video conferencing. This session is critical for finalizing the company’s performance metrics for the fiscal year ending March 31, 2026.
Financial Review and Shareholder Returns
During this meeting, the Board will review the audited standalone and consolidated financial results covering the fourth quarter and the full fiscal year. Shareholders are also awaiting the board’s decision regarding the final dividend proposal for equity shares, which reflects the company’s commitment to returning value to its investors.
Trading Window Update
In accordance with internal compliance protocols, the trading window for company securities has been closed since April 01, 2026. This restriction applies to all designated persons and their immediate relatives. The trading window is officially scheduled to reopen on Thursday, May 14, 2026, following the conclusion of the board proceedings and the subsequent publication of the financial results.
Source: BSE
